G71115102

(CUSIP Number)
Byland Christina Elisabeth
167-169 Great Portland Street,, 5th Floor,
London, X0, W1W 5PF
44 (0) 207 754 3735

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/28/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
(1) Of the 59,146,907 ordinary shares reported as beneficially owned with sole voting and dispositive power, 9,200,000 ordinary shares are not included, as such ordinary shares are issuable upon exercise of warrants for the purchase of ordinary shares, each of which are not currently exercisable due to certain beneficial ownership limitations. (2) Row 13 is calculated based on 85,956,495 ordinary shares outstanding as of October 27, 2026


SCHEDULE 13D

Byland Christina Elisabeth
Signature:/s/ Byland Christina Elisabeth
Name/Title:Individual
Date:10/28/2026